Cannabidiol, also known as cbd for dogs, is a very important phytochemical that has recently gained attention due to its potential as a major player in the treatment of multiple sclerosis. Cannabidiol has been shown to reduce inflammation, protect nerve cells from death and facilitate the repair of myelin. By doing so it provides a basis for why it may be effective in treating MS symptoms. However, further studies are still needed to support this finding.
Cannabidiol or CBD is considered relatively safe when used as a dietary supplement. No long term side effects have been reported by those who use it. In fact, there are no reported deaths from taking it. However, it should be considered that cbd oil is not the only source of CBD. In fact, other botanical sources of CBD include hemp and jojoba.
While it is unlikely that CBD will be considered an alternative to medications like antidepressants, it is an interesting prospect that this substance could play a role in the management of the symptoms associated with depression. Because of its remarkable anti-inflammatory properties, CBD has the ability to reduce inflammation. This would make it a potentially useful medication for people experiencing arthritis, muscle spasticity, severe pain and menstrual pain. Although it is not yet studied in detail, CBD has been shown to relieve the symptoms of menopause and menstrual pain.
Apart from the potential use as a natural treatment for mood disorders, CBD has also shown promise in the area of substance abuse treatment. The substance has been used in Europe for years and has had a number of law enforcement officials lauding its medicinal value. When administered in the proper dosage and mixed with other substances, CBD has been shown to help patients overcome repeated drug addictions. It appears that there is a genetic component to addiction and when administered in the proper form, CBD is an extremely powerful weapon in the fight against substance abuse.
A separate study found that CBD significantly reduced the frequency and the severity of epileptic seizures in children suffering from primary epilepsy. The study also showed that CBD significantly decreased the percentage of children who had a history of seizures compared to those without a history of epilepsy. The frequency of seizure was found to be lower in children using CBD than in placebo controls. The treatment also seemed to prevent the occurrence of epileptic seizures associated with the treatment for spasticity. Spasticity is often associated with severe health problems like obesity and type II diabetes.
These promising results suggest that CBD may have positive effects on other seizure disorders including epileptic seizures and attention deficit disorder (ADD) symptoms. Though it is too early to draw any conclusion on the impact of CBD on these disorders, the results of these studies provide strong anecdotal evidence that the herb can help to treat these disorders. Further studies should be conducted to evaluate CBD’s effect on more serious syndromes such as schizophrenia, bipolar and post traumatic stress disorder (PTSD) and more recently, Parkinson’s disease and attention deficit disorder. The benefits of CBD will only become clearer in the coming years with additional research.